 |
138 Diseases |  |
26 Trials |
|
26 Trials |  |
791 News |  |
| «12345678910» |
- phenytoin / Generic mfg., megestrol / Generic mfg.
New trial: Phenytoin for Memory Impairment Secondary to Megestrol (clinicaltrials.gov) - Nov 3, 2015
P0, N=20, Recruiting, Sponsor: University of Texas Southwestern Medical Center
- megestrol / Generic mfg.
New trial, Metastases: Randomized Control Trial (RCT) of Early Palliative Care for HCC (clinicaltrials.gov) - Sep 22, 2015
P=N/A, N=72, Not yet recruiting, Sponsor: The University of Texas Health Science Center, Houston
- || Virexxa (sodium cridanimod) / Xenetic Biosci
Trial primary completion date: Virexxa (Sodium Cridanimod) w/Progestin Therapy in Pts w/Progesterone Receptor Neg Recurrent/Persistent Endometrial CA (clinicaltrials.gov) - Aug 21, 2015
P2, N=58, Recruiting, Sponsor: Kevelt AS
Trial primary completion date: Apr 2017 --> Jan 2018
- Torisel (temsirolimus) / Pfizer
Trial primary completion date, Metastases: Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer (clinicaltrials.gov) - Aug 13, 2015
P2, N=84, Active, not recruiting, Sponsor: National Cancer Institute (NCI)
Trial primary completion date: Apr 2017 --> Jan 2018 Trial primary completion date: Jul 2014 --> Jul 2016
- megestrol / Generic mfg.
Trial completion, Enrollment change: Megestrol in Treating Patients With Endometrial Neoplasia or Endometrial Hyperplasia (clinicaltrials.gov) - May 28, 2015
P2, N=9, Completed, Sponsor: Gynecologic Oncology Group
Trial primary completion date: Jul 2014 --> Jul 2016 Active, not recruiting --> Completed | N=260 --> 9
- ||| megestrol / Generic mfg.
New P1 trial: Pharmacokinetics and Safety Study of Apetrol ES (clinicaltrials.gov) - May 19, 2015
P1, N=79, Completed, Sponsor: LG Life Sciences
- || everolimus / Generic mfg.
Trial primary completion date, Metastases: Phase II Study of Everolimus Beyond Progression (clinicaltrials.gov) - May 1, 2015
P2, N=70, Recruiting, Sponsor: Emory University
Active, not recruiting --> Completed | N=260 --> 9 Trial primary completion date: Nov 2016 --> Feb 2017
- amitriptyline / Generic mfg.
Trial completion, Enrollment change, Trial primary completion date: Trial of Amitriptyline for Chronic Oral Food Refusal in Children 9 Months to 8 Years of Age (clinicaltrials.gov) - Apr 25, 2015
P2, N=19, Completed, Sponsor: Ann Davis, PhD, MPH, ABPP
Trial primary completion date: Nov 2016 --> Feb 2017 Active, not recruiting --> Completed | N=72 --> 19 | Trial primary completion date: Aug 2014 --> Dec 2014
- megestrol / Generic mfg.
Phase classification, Enrollment change, Trial primary completion date: ColErn: Can Malnutrition be Prevented in Patient With Colorectal Cancer Stage Dukes D? (clinicaltrials.gov) - Apr 8, 2015
P=N/A, N=0, Withdrawn, Sponsor: Norwegian University of Science and Technology
Active, not recruiting --> Completed | N=72 --> 19 | Trial primary completion date: Aug 2014 --> Dec 2014 Phase classification: P3 --> P=N/A | N=250 --> 0 | Trial primary completion date: Mar 2008 --> Feb 2009
- |||| everolimus / Generic mfg.
Enrollment open, Metastases: Phase II Study of Everolimus Beyond Progression (clinicaltrials.gov) - Dec 6, 2014
P2, N=70, Recruiting, Sponsor: Emory University
Phase classification: P3 --> P=N/A | N=250 --> 0 | Trial primary completion date: Mar 2008 --> Feb 2009 Not yet recruiting --> Recruiting
- |||| Virexxa (sodium cridanimod) / Xenetic Biosci
Enrollment open, Trial initiation date, Trial primary completion date: Virexxa (Sodium Cridanimod) w/Progestin Therapy in Pts w/Progesterone Receptor Neg Recurrent/Persistent Endometrial CA (clinicaltrials.gov) - Nov 17, 2014
P2, N=58, Recruiting, Sponsor: Kevelt AS
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting | Initiation date: Mar 2014 --> Sep 2014 | Trial primary completion date: Oct 2015 --> Apr 2017
- ||||| everolimus / Generic mfg.
New P2 trial, Metastases: Phase II Study of Everolimus Beyond Progression (clinicaltrials.gov) - Oct 22, 2014
P2, N=70, Not yet recruiting, Sponsor: Emory University
- Torisel (temsirolimus) / Pfizer
Trial primary completion date, Metastases: Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer (clinicaltrials.gov) - Oct 10, 2014
P2, N=74, Active, not recruiting, Sponsor: National Cancer Institute (NCI)
Not yet recruiting --> Recruiting | Initiation date: Mar 2014 --> Sep 2014 | Trial primary completion date: Oct 2015 --> Apr 2017 Trial primary completion date: Jan 2014 --> Jul 2014
- megestrol / Generic mfg.
Enrollment change, Trial withdrawal, Head-to-Head: Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer (clinicaltrials.gov) - Sep 10, 2014
P2, N=0, Withdrawn, Sponsor: University of Southern California
Trial primary completion date: Jan 2014 --> Jul 2014 N=130 --> 0 | Not yet recruiting --> Withdrawn
- amitriptyline / Generic mfg.
Enrollment closed: Trial of Amitriptyline for Chronic Oral Food Refusal in Children 9 Months to 8 Years of Age (clinicaltrials.gov) - Jul 27, 2014
P2, N=72, Active, not recruiting, Sponsor: Ann Davis, PhD, MPH, ABPP
N=130 --> 0 | Not yet recruiting --> Withdrawn Recruiting --> Active, not recruiting
- megestrol / Generic mfg.
Trial completion: Phase 1 Study of Daewon-ES(B) & Megace in Healthy Male Volunteers Under Fasting and Fed Condition (clinicaltrials.gov) - Jun 26, 2014
P1, N=56, Completed, Sponsor: Asan Medical Center
Recruiting --> Active, not recruiting Recruiting --> Completed
- metformin / Generic mfg., megestrol / Generic mfg.
Phase classification: Megestrol Acetate Plus Metformin to Megestrol Acetate in Patients With Endometrial Atypical Hyperplasia or Early Stage Endometrial Adenocarcinoma (clinicaltrials.gov) - Jun 12, 2014
P2, N=150, Recruiting, Sponsor: Xiaojun Chen
Recruiting --> Completed Phase classification: P4 --> P2
- metformin / Generic mfg., megestrol / Generic mfg.
Trial primary completion date: Megestrol Acetate Plus Metformin to Megestrol Acetate in Patients With Endometrial Atypical Hyperplasia or Early Stage Endometrial Adenocarcinoma (clinicaltrials.gov) - May 13, 2014
P2, N=150, Recruiting, Sponsor: Xiaojun Chen
Phase classification: P4 --> P2 Trial primary completion date: Oct 2018 --> Oct 2017
- metformin / Generic mfg., megestrol / Generic mfg.
Enrollment change: Megestrol Acetate Plus Metformin to Megestrol Acetate in Patients With Endometrial Atypical Hyperplasia or Early Stage Endometrial Adenocarcinoma (clinicaltrials.gov) - May 13, 2014
P2, N=150, Recruiting, Sponsor: Xiaojun Chen
Trial primary completion date: Oct 2018 --> Oct 2017 N=106 --> 150
- metformin / Generic mfg., megestrol / Generic mfg.
Enrollment open: Megestrol Acetate Plus Metformin to Megestrol Acetate in Patients With Endometrial Atypical Hyperplasia or Early Stage Endometrial Adenocarcinoma (clinicaltrials.gov) - May 13, 2014
P2, N=150, Recruiting, Sponsor: Xiaojun Chen
N=106 --> 150 Not yet recruiting --> Recruiting
- Torisel (temsirolimus) / Pfizer
Enrollment change, Metastases: Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer (clinicaltrials.gov) - Apr 17, 2014
P2, N=67, Active, not recruiting, Sponsor: National Cancer Institute (NCI)
Not yet recruiting --> Recruiting N=84 --> 67
- | megestrol / Generic mfg.
Trial completion: Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment (clinicaltrials.gov) - Feb 22, 2014
P2, N=70, Completed, Sponsor: University of South Florida
N=84 --> 67 Active, not recruiting --> Completed
- | megestrol / Generic mfg.
Trial completion: Megestrol and Exercise in Treating Patients With Cancer-Related Weight Loss (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Northwestern University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Neupogen (filgrastim) / Kyowa Kirin, Amgen, NN1213 / Novo Nordisk
Trial completion, Metastases: Sequential High-Dose Chemotherapy and Stem Cell Transplantation in Treating Patients With Chemotherapy-Sensitive Metastatic Breast Cancer (clinicaltrials.gov) - Feb 19, 2014
P2, N=40, Completed, Sponsor: Yale University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | megestrol / Generic mfg.
Trial completion: The Safety and Effectiveness of Megace in HIV-Infected Women (clinicaltrials.gov) - Feb 19, 2014
P4, N=40, Completed, Sponsor: Bristol-Myers Squibb
Active, not recruiting --> Completed No longer recruiting --> Completed
- megestrol / Generic mfg.
Trial completion: A Study of Different Doses of Megestrol Acetate in Patients With AIDS Who Have Anorexia and Malnutrition (clinicaltrials.gov) - Feb 19, 2014
P2, N=0, Completed, Sponsor: Bristol-Myers Squibb
No longer recruiting --> Completed No longer recruiting --> Completed
- megestrol / Generic mfg.
Trial completion: A Study Comparing Megestrol Acetate at 800 mg/Day, and Placebo in AIDS Patients With Anorexia and Cachexia (clinicaltrials.gov) - Feb 19, 2014
P3, N=0, Completed, Sponsor: Bristol-Myers Squibb
No longer recruiting --> Completed No longer recruiting --> Completed
- ||||| Virexxa (sodium cridanimod) / Xenetic Biosci
New P2 trial: Virexxa (Sodium Cridanimod) w/Progestin Therapy in Pts w/Progesterone Receptor Neg Recurrent/Persistent Endometrial CA (clinicaltrials.gov) - Feb 13, 2014
P2, N=58, Not yet recruiting, Sponsor: Kevelt AS
- ||||| everolimus / Generic mfg., sorafenib / Generic mfg.
Enrollment change, Metastases: EVOLVE-1: Global Study Looking at the Combination of RAD001 Plus Best Supportive Care (BSC) and Placebo Plus BSC to Treat Patients With Advanced Hepatocellular Carcinoma. (clinicaltrials.gov) - Feb 12, 2014
P3, N=546, Completed, Sponsor: Novartis Pharmaceuticals
No longer recruiting --> Completed N=761 --> 546
- ||||||| everolimus / Generic mfg., sorafenib / Generic mfg.
Trial completion, Metastases: EVOLVE-1: Global Study Looking at the Combination of RAD001 Plus Best Supportive Care (BSC) and Placebo Plus BSC to Treat Patients With Advanced Hepatocellular Carcinoma. (clinicaltrials.gov) - Feb 12, 2014
P3, N=546, Completed, Sponsor: Novartis Pharmaceuticals
N=761 --> 546 Active, not recruiting --> Completed
- megestrol / Generic mfg., mirtazapine / Generic mfg.
Trial withdrawal: Megestrol Acetate With or Without Mirtazapine in Treating Cancer Patients With Weight Loss or Loss of Appetite (clinicaltrials.gov) - Jan 30, 2014
P2, N=0, Withdrawn, Sponsor: Washington University School of Medicine
Active, not recruiting --> Completed Not yet recruiting --> Withdrawn
- megestrol / Generic mfg., mirtazapine / Generic mfg.
Enrollment change: Megestrol Acetate With or Without Mirtazapine in Treating Cancer Patients With Weight Loss or Loss of Appetite (clinicaltrials.gov) - Jan 30, 2014
P2, N=0, Withdrawn, Sponsor: Washington University School of Medicine
Not yet recruiting --> Withdrawn N=106 --> 0
- megestrol / Generic mfg.
Trial initiation date, Head-to-Head: Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer (clinicaltrials.gov) - Jan 26, 2014
P2, N=130, Not yet recruiting, Sponsor: University of Southern California
N=106 --> 0 Initiation date: Oct 2013 --> Mar 2014
- megestrol / Generic mfg.
Enrollment change: Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate (clinicaltrials.gov) - Nov 19, 2013
P2, N=31, Completed, Sponsor: New York University School of Medicine
Initiation date: Oct 2013 --> Mar 2014 N=40 --> 31
- megestrol / Generic mfg.
Trial completion: Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate (clinicaltrials.gov) - Nov 19, 2013
P2, N=31, Completed, Sponsor: New York University School of Medicine
N=40 --> 31 Active, not recruiting --> Completed
- megestrol / Generic mfg.
Enrollment change: Pharmacokinetics and Safety of Transdermal Megestrol Acetate (clinicaltrials.gov) - Oct 23, 2013
P4, N=0, Withdrawn, Sponsor: Milton S. Hershey Medical Center
Active, not recruiting --> Completed N=10 --> 0
- | metformin / Generic mfg., megestrol / Generic mfg.
New P4 trial: Megestrol Acetate Plus Metformin to Megestrol Acetate in Patients With Endometrial Atypical Hyperplasia or Early Stage Endometrial Adenocarcinoma (clinicaltrials.gov) - Oct 15, 2013
P4, N=106, Not yet recruiting, Sponsor: Xiaojun Chen
- | megestrol / Generic mfg.
Trial completion, Surgery: Megestrol in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery (clinicaltrials.gov) - Sep 18, 2013
P3, N=300, Completed, Sponsor: National Medical Research Council (NMRC), Singapore
N=10 --> 0 Active, not recruiting --> Completed
- | megestrol / Generic mfg.
New P2 trial, Head-to-Head: Megestrol Acetate or Levonorgestrel-Releasing Intrauterine System in Treating Patients With Atypical Endometrial Hyperplasia or Endometrial Cancer (clinicaltrials.gov) - Sep 12, 2013
P2, N=130, Not yet recruiting, Sponsor: University of Southern California
- |||| irosustat (BN 83495) / Ipsen
Trial completion, Metastases: The Study of Oral Steroid Sulphatase Inhibitor BN83495 Versus Megestrol Acetate (MA) in Women With Advanced or Recurrent Endometrial Cancer (clinicaltrials.gov) - Jul 15, 2013
P2, N=73, Completed, Sponsor: Ipsen
Active, not recruiting --> Completed Active, not recruiting --> Completed
- megestrol / Generic mfg., mirtazapine / Generic mfg.
Trial initiation date: Megestrol Acetate With or Without Mirtazapine in Treating Cancer Patients With Weight Loss or Loss of Appetite (clinicaltrials.gov) - Jun 27, 2013
P2, N=0, Withdrawn, Sponsor: Washington University School of Medicine
Active, not recruiting --> Completed Initiation date: Apr 2012 --> Sep 2013
- Trial termination, Metastases: Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer (clinicaltrials.gov) - Apr 9, 2013
P3, N=0, Terminated, Sponsor: Gynecologic Oncology Group
Initiation date: Apr 2012 --> Sep 2013 Completed --> Terminated
- megestrol / Generic mfg.
Trial termination: Megestrol Acetate in Treating Weight Loss or Anorexia in Young Patients With Malignancies Who Are Undergoing Radiation Therapy and/or Chemotherapy (clinicaltrials.gov) - Mar 28, 2013
P2, N=1, Terminated, Sponsor: Mayo Clinic
Completed --> Terminated Active, not recruiting --> Terminated; The study closed due to slow accrual.
- megestrol / Generic mfg.
Enrollment change: Megestrol Acetate in Treating Weight Loss or Anorexia in Young Patients With Malignancies Who Are Undergoing Radiation Therapy and/or Chemotherapy (clinicaltrials.gov) - Mar 28, 2013
P2, N=1, Terminated, Sponsor: Mayo Clinic
Active, not recruiting --> Terminated; The study closed due to slow accrual. N=88 --> 1
- | megestrol / Generic mfg.
Trial completion: Phase 1 Study of Daewon-ES(B) & Megace in Healthy Male Volunteers Under Fed Condition (clinicaltrials.gov) - Jan 20, 2013
P1, N=28, Completed, Sponsor: Daewon Pharmaceutical Co., Ltd.
N=88 --> 1 Recruiting --> Completed
- megestrol / Generic mfg.
Enrollment change: Pharmacokinetics and Safety Study of Apetrol ES in Healthy Male Volunteers (clinicaltrials.gov) - Oct 7, 2012
P1, N=38, Completed, Sponsor: LG Life Sciences
Recruiting --> Completed N=48 --> 38
- | megestrol / Generic mfg.
Trial completion: Pharmacokinetics and Safety Study of Apetrol ES in Healthy Male Volunteers (clinicaltrials.gov) - Oct 7, 2012
P1, N=38, Completed, Sponsor: LG Life Sciences
N=48 --> 38 Active, not recruiting --> Completed
- |||| Taltorvic (ridaforolimus) / Takeda, Merck (MSD)
Trial completion, Metastases: Clinical Trial of Ridaforolimus Compared to Progestin or Chemotherapy for Advanced Endometrial Carcinoma (MK-8669-007 AM6) (clinicaltrials.gov) - Aug 8, 2012
P2, N=130, Completed, Sponsor: Merck Sharp & Dohme Corp.
Active, not recruiting --> Completed Active, not recruiting --> Completed
- cyclophosphamide / Generic mfg., megestrol / Generic mfg.
Trial completion: PALANGI-0601: Metronomic Chemotherapy by Cyclophosphamide Versus Megestrol in Palliative Cancer (clinicaltrials.gov) - Jul 19, 2012
P2, N=88, Completed, Sponsor: Centre Oscar Lambret
Active, not recruiting --> Completed Active, not recruiting --> Completed
- megestrol / Generic mfg.
Trial completion: A Randomized Clinical Trial of Megestrol Acetate as an Appetite Stimulant in Malnourished Children With Cancer (clinicaltrials.gov) - Jul 10, 2012
P=N/A, N=26, Completed, Sponsor: University of British Columbia
Active, not recruiting --> Completed Recruiting --> Completed